9:00

Andy Lawton
Head of Biometrics & Data Management
Boehringer Ingelheim (UK)
Opening remarks from the Chair
STREAMLINING DATA PROCESSES AND REDUCING COSTS THROUGH THE EFFECTIVE APPLICATION OF STANDARDS
9:10
Pierre Verroye
Executive Director, Clinical Data Management and Clinical Programming
Human Genome Sciences
Overcoming obstacles in standardization to improve data collection
- CDASH data collection standard and how it maps to the SDTM
- Dealing with counterintuitive naming conventions and problems for SAS programmers
- Understanding practical implementation goals for better results
- Facilitating interoperability between clinical systems including data from EHRs and between numerous clinical data systems and trial sites
- Identifying when standards help and when they threaten productivity
09:50
Scott Getzin
Data Scientist
Eli Lilly
Ensuring Consistency in Clinical Data Communication
- Content vocabulary is the foundation for data standards
- A common industry vocabulary is needed
- Discussion on Lilly's approach and contribution to the cause
- Clinical research and healthcare have different needs and processes
- Industry alignment on messaging and content are key
10:30 Morning Refreshments
IMPROVING RESOURCE ALLOCATION TO ENHANCE DATA RELIABILITY AND TRIAL OUTCOMES
11:15
Pierre Verroye
Executive Director, Clinical Data Management and Clinical Programming
Human Genome Sciences
Darlene Kalinowski
Associate Director, EDC Operations
Bristol-Myers Squibb
Panel Session: Increasing data reliability in a globalized trial environment
- What are the best practice approaches to coordinating data management functions across multiple international trial sites to achieve consistent reliable observations and outcomes?
- How to decide upon the division of resources for maximum cost effectiveness
- Outlining practical collaboration tools and techniques to keep the data moving and prevent blockages
- Solutions for monitoring, reporting and administering global trials
Katherine Arbour
Director, Clinical Data Management
Ariad Pharmaceuticals
Case Study: Hybrid CRO and sponsor partnerships to produce cost-effective outcomes for global EDC oncology trials
- Determining the participants and allocating responsiblities and decision-making to each
- Understanding the site's relations with EDC and mimizing the tool's capabilities
- Determining critical paths in EDC trials designed for large, global
oncology trials
- Cost-effective models for CRO and sponsor hybrid approaches to
managing data collection in an EDC trial
Katerine Arbour
Director, Clinical Data Management
Ariad Pharmaceuticals
Shawn Wang
President
MedXView
Ram Kamath
President
V Soft
Nidhi Bajpai
Manager - Clinical Data Management
Panacea Biotec LTD
Panel Session: Getting best results from outsourced data management functions
- Strategies for achieving cost effective data management in the current economic climate
- Managing the opportunities and risks of different outsourcing options
- Avoiding costly mistakes by choosing the right partner to fit the needs of your trial
- Keeping control through optimizing timelines and costs in the data management process
Darlene Kalinowski
Associate Director, EDC Operations
Bristol-Myers Squibb
How to realize the benefi ts of EDC in trials conducted in emerging countries
- Successfully managing trial circumstances affecting operability of EDC tools
- Overcoming lack of technology infrastructures in clinical trials in emerging countries
- Solutions to communication problems in locations that cannot support EDC
- Identifying hidden costs of the trial environment - the impact on data capture and integration